EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NLRP3 inflammasome inhibition protects against intracranial aneurysm rupture and alters the phenotype of infiltrating macrophages

William S Dodd, Devan Patel, Kartik Motwani, Brandon Lucke-Wold, Koji Hosaka, Brian L Hoh

Frontiers in Stroke · 19.07.2023 · 2

DOI: 10.3389/fstro.2023.1202137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Stroke, online erschienen am 19.07.2023. Verfasst von William S Dodd und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, College of Medicine, University of Florida, Gainesville, FL, United States. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Aneurysmal subarachnoid hemorrhage is a devastating cerebrovascular disease associated with high morbidity and mortality. Macrophage-mediated mural inflammation is a key pathogenic component contributing to aneurysm rupture.

Objective

To investigate the effect of pharmacological inhibition of the NLRP3 inflammasome on aneurysm rupture.

Methods

Cerebral aneurysms were induced in C57BL/6 mice with a combination of hypertension and an intracranial dose of elastase. Mice were treated with either 40 mg/kg of MCC950 or saline via intraperitoneal injections. Vascular tissue at the circle of Willis was harvested for analysis via immunofluorescent microscopy or qPCR.

Results

NLRP3 + cells are more common in the aneurysm tissue compared to the normal cerebral vasculature. The mRNA expression of the downstream NLRP3 pathway components caspase-1, IL-1β, and GSDMD is also increased in the aneurysm tissue compared to healthy vessels. There was no difference in the aneurysm formation rate between MCC950- and vehicle-treated mice; however, MCC950 treatment significantly reduced aneurysm rupture rate. There was no difference in systemic blood pressure between both groups. MCC950 treatment also extended the symptom-free survival of mice after aneurysm induction. Mechanistically, NLRP3 inhibition decreased the phenotype polarization of infiltrating macrophages without affecting the total number of macrophages in the vessel wall.

Conclusions

Our results indicate that the NLRP3 inflammasome contributes to aneurysm rupture and macrophage polarization within the vessel wall. The NLRP3 pathway is a promising therapeutic target for the development of therapeutics to prevent aneurysmal hemorrhagic stroke.

Schlagwörter

Stichwörter der Autor:innen

NLRP3 inflammasomecerebral aneurysmshemorrhagic strokemacrophagessubarachnoid hemorrhage

Autor:innen und Institutionen

  • Department of Neurosurgery, College of Medicine, University of Florida, Gainesville, FL, United States.
  • Department of Neurosurgery, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, Buffalo, NY, United States.

Förderung

  • National Institutes of Health

Zitieren

APA

Dodd, W. S., Patel, D., Motwani, K., Lucke-Wold, B., Hosaka, K., & Hoh, B. L. (2023). NLRP3 inflammasome inhibition protects against intracranial aneurysm rupture and alters the phenotype of infiltrating macrophages. Frontiers in Stroke, 2. https://doi.org/10.3389/fstro.2023.1202137

Vancouver

Dodd WS, Patel D, Motwani K, Lucke-Wold B, Hosaka K, Hoh BL. NLRP3 inflammasome inhibition protects against intracranial aneurysm rupture and alters the phenotype of infiltrating macrophages. Frontiers in Stroke. 2023;2. doi:10.3389/fstro.2023.1202137

BibTeX
@article{Dodd2023,
  author = {Dodd, William S and Patel, Devan and Motwani, Kartik and Lucke-Wold, Brandon and Hosaka, Koji and Hoh, Brian L},
  title = {NLRP3 inflammasome inhibition protects against intracranial aneurysm rupture and alters the phenotype of infiltrating macrophages},
  journal = {Frontiers in Stroke},
  year = {2023},
  volume = {2},
  doi = {10.3389/fstro.2023.1202137}
}
Kostenlos starten →